TIME convened its third annual TIME100 Health Leadership Forum in New York City on [Date of Forum, likely Sept 8, 2026 based on source date]. The forum focused on advancing healthcare through discussions on equity, longevity, and solution-driven care.
The event gathered individuals from the TIME and TIME100 Health communities, as well as other key figures actively shaping the health industry. The goal was to foster idea sharing, build connections, and propel important work forward.
"Tonight, we’ll bring together leaders taking on some of the most important challenges in health today to share ideas, build connections, and move important work forward," said TIME Chief Executive Officer Jessica Sibley. "We thank our partners for their commitment to advancing health and driving meaningful change."
TIME Executive Editor and Chief Strategy Officer Dan Macsai, who oversees the TIME100 franchise, noted the forum's value in understanding the future of health. "The TIME100 Health Leadership Forum gives us a chance to hear directly from those shaping the future of health, learn from their experiences and ideas, and gain a clearer view of where health is headed next," Macsai stated.
Now in its third year, the TIME100 Health Leadership Forum is a key component of TIME's ongoing initiative to highlight people and stories that are impacting the health sector, complementing the annual TIME100 Health list.
Speakers and participants included Maria Shriver, founder of Cleveland Clinic’s Women’s Alzheimer’s Movement; Dr. Andrea Cercek, gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center; Dr. Judith Joseph, psychiatrist, researcher, and author; Shane Jacobson, CEO of the American Cancer Society and the American Cancer Society Cancer Action Network; Ashley McEvoy, CEO of Insulet Corporation; David Sinclair, professor at Harvard Medical School; Dr. Eneida R. Nemecek, Director of Pediatric Cell Therapy and Transplant and Cancer Clinical Research at Oregon Health & Science University; Cindy Perettie, executive vice president of Kite; Jack Jia, founder and CEO of Musely; Garrett Vogel, on-air host and T1D advocate; Jennifer Garrison, neuroscientist and women’s health biotech founder; Amy Ronneberg, CEO of NMDP; and Dr. David L. Porter, director of the Center for Cell Therapy and Transplant at Penn Medicine.
The forum was presented by signature partners The American Cancer Society, Insulet, Kite—a Gilead Sciences company, and Musely, with supporting partner NMDP.